Anya Biopharm (ROCO:7776) EPS (Basic): NT$-1.30 (TTM As of Dec. 2025)


ROCO:7776 Anya Biopharm Inc ROCO:7776
12 GF Score
Price NT$31.80
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm EPS (Basic)?

Anya Biopharm ROCO:7776 12 EPS (Basic) is NT$-1.30 as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Anya Biopharm's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$0.09. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.30.

Anya Biopharm's EPS (Diluted) for the six months ended in Dec. 2025 was NT$0.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.30.

Anya Biopharm's EPS without NRI for the six months ended in Dec. 2025 was NT$0.09. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -1.30.

During the past 3 years, the average EPS without NRI Growth Rate was 58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Anya Biopharm's highest 3-Year average EPS without NRI Growth Rate was 58.60% per year. The lowest was 58.60% per year. And the median was 58.60% per year.

Anya Biopharm  (ROCO:7776) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Anya Biopharm EPS (Basic) Related Terms

Anya Biopharm EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm EPS (Basic) Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS (Basic)
-18.35 -12.32 -1.12 -1.30

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial -0.88 -1.79 -0.14 -1.39 0.09
ROCO:7776
12GF Score
Anya Biopharm Inc ROCO:7776
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Anya Biopharm's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-64.022-0)/49.101
=-1.30

Anya Biopharm's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.283-0)/49.101
=0.09

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$-1.30 mean?
Anya Biopharm (ROCO:7776) has a EPS (Basic) of NT$-1.30 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Anya Biopharm and its competitors.
Is Anya Biopharm's EPS (Basic) too high?
Anya Biopharm's current EPS (Basic) is NT$-1.30. Overall, Anya Biopharm has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's EPS (Basic) compare to VRTX and REGN?
Anya Biopharm's EPS (Basic) of NT$-1.30 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current EPS (Basic) is NT$-1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current EPS (Basic) of NT$-1.30. The current EPS (Basic) is NT$-1.30. Anya Biopharm's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current EPS (Basic) is NT$-1.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
12GF Score

Get the complete analysis for ROCO:7776

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.80
Price